Company intelligence / Profile preview

LevEllis

Asheville, North Carolina, United Stateslevellis.com ↗

Ownership: Private
Development stage: Other

Overview

LevEllis is a global skincare retailer that has secured exclusive worldwide rights to market and distribute AIVITA Biomedical’s proprietary stem-cell-derived skincare formulations. These formulations were previously sold as Root of Skin™ and have demonstrated strong clinical dermatologist support and commercial success in markets like QVC Japan. The active ingredient leverages regenerative medicine techniques adapted from FDA-regulated clinical trials by AIVITA Biomedical. Under Dr. Laura Ellis’ leadership, LevEllis will reintroduce these products under the new Provoque™ brand.

Therapeutic areas: Dermatology
Modalities: BiologicCosmetic formulation
Industry: Non-Drug Biotech

Partnerships

AIVITA Biomedical

Beyond the preview

Go deeper on LevEllis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LevEllis.

Explore the full profile